Answers are grounded in this paper and cite their sources.
Transient RNA delivery offers a practical approach to programmable genome editing without introducing editor-encoding DNA, but editing performance depends on reagent design, delivery conditions, and target accessibility. Here, we evaluated an RNA-based editing workflow built around a cytosine base editor derived from targeted activation-induced cytidine deaminase (AID)-mediated mutagenesis (TAM). Systematic adjustment of editor mRNA and guide RNA dosage, poly(A) tail configuration, and untranslated regions identified parameters influencing cytosine-to-thymine conversion; viability remained high at 24 h under the tested RNA-dose conditions. Further optimized electroporation enabled efficient reporter mRNA delivery into primary human CD8+ T cells. In two independent donor experiments, targeted nucleotide conversion at the endogenous CD3E locus and the CD3-negative fraction were higher after sequential than after single electroporation. To investigate splice-site editing, we screened AID–Cas9 combinations targeting the mouse Nr4a2 exon 3 splice acceptor and generated mutant mice through embryo editing and subsequent breeding. Sanger sequencing of genomic DNA from primary CD8+ T cells confirmed the intended Nr4a2 splice-site mutation, while Hi-TOM-based targeted cDNA amplicon sequencing revealed altered splice-junction patterns, including the emergence of an unexpected splice junction in mutant cells. However, no statistically significant differences in tumor progression were detected in the B16-OVA adoptive transfer or B16F10 tumor models. Together, these findings provide a practical framework for transient RNA-based base editing in primary T cells and targeted modification of splice-regulatory sequences, while highlighting the complexity of splice-site editing outcomes.
No takes yet. Share an insight, caveat, or question.
Liang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: